Acadia Healthcare (ACHC) Tops Q4 EPS by 49c, Guidance Misses Consensus
Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $1.13, $0.49 better than the analyst estimate of $0.64. Revenue for the quarter came in at $541.3 million versus the consensus estimate of $748.57 million.
GUIDANCE:
Acadia Healthcare sees FY2021 EPS of $2.20-$2.45, versus the consensus of $2.56. Acadia Healthcare sees FY2021 revenue of $2.23-2.28 billion, versus the consensus of $3.12 billion.
For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.
